Treatment of osteopenia and osteoporosis after kidney transplantation

Transplantation

Volumn 66, Issue 8, 1998, Pages 1004-1008

  Grotz, Wolfgang H ^a,c   Rump, Lars Christian ^a   Niessen, Annette ^a   Schmidt Gayk, Heinrich ^b   Reichelt, Achim ^a   Kirste, Günter ^a   Olschewski, Manfred ^a   Schollmeyer, Peter J ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Laboratory Group   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; CLODRONIC ACID;

ADULT; ARTICLE; BONE DENSITY; BONE PAIN; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; FRACTURE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY TRANSPLANTATION; MALE; ORAL DRUG ADMINISTRATION; OSTEOPENIA; OSTEOPOROSIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL;

ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; ADULT; BONE DENSITY; BONE DISEASES, METABOLIC; CALCITONIN; CALCIUM; CLODRONIC ACID; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; OSTEOPOROSIS; PILOT PROJECTS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; SEX CHARACTERISTICS;

EID: 0032573142     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199810270-00007     Document Type: Article

References (16)

1. Torres A, Machado M, Concepcion MT, et al. Influence of vitamin D receptor genotype on bone mass changes after renal transplantation. Kidney Int 1996; 50: 1726.
2. Grotz WH, Mundinger FA, Gugel B, Exner V, Kirste G, Schollmeyer P. Bone mineral density after kidney transplantation: a cross-sectional study in 190 graft recipients up to 20 years after transplantation. Transplantation 1995; 59: 982.
3. Grotz WH, Mundinger FA, Rasenack J, et al. Bone loss after kidney transplantation: a longitudinal study in 115 graft recipients. Nephrol Dial Transplant 1995; 10: 2096.
4. Movsowitz C, Epstein S, Fallon M, Ismail F, Thomas S. Cyclosporin A in vivo produces severe osteopenia in the rat: effect of dose and duration of administration. Endocrinology 1988; 123: 2571.
5. Grotz W, Mundinger A, Gugel B, Exner V, Kirste G, Schollmeyer P. Bone fracture and osteodensitometry with dual energy x-ray absorptiometry in kidney transplant recipients. Transplantation 1994; 58: 912.
6. Wildermuth S, Dittrich K, Schmidt-Gayk H, Zahn I, Riordan JLH. Scintillation proximity assay for calcitriol in serum without high pressure liquid chromatography. Clin Chim Acta 1993; 220: 61.
7. Black D, Duncan A, Robins S. Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion-paired reversed-phase high-performance liquid chromatography. Anal Biochem 1988; 169: 197.
8. Fleisch H. Bisphosphonates. Pharmacology and use in treatment of tumor- induced hypercalcemic and metastatic bone disease. Drugs 1991; 42: 919.
9. Nicholson GC, Moseley JM, Sexton PM, Mendelsohn AO, Martin TJ. Abundant calcitonin receptors in isolated osteoclasts. J Clin Invest 1986; 78: 355.
10. Sahni M, Guenther HL, Fleisch H, Collin P, Martin TJ. Bisphosphonates act on rat bone resorption through the mediation of osteoblasts. J Clin Invest 1993; 91: 2004.
11. Giannini S, D'Angelo A, Malvasi L, et al. Effects of one-year cyclical treatment with clodronate on postmenopausal bone loss. Bone 1993; 14: 137.
12. Overgaard K, Hansen MA, Jensen SB, Christiansen C. Effect of salmon calcitonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose response study. Br Med J 1992; 305: 556.
13. Sambrook P, Birmingham J, Kelly P, et al. Prevention of corticoid osteoporosis: a comparison of calcium, calcitriol and calcitonin. N Engl J Med 1993; 328: 1747.
14. Julian B, Laskow D, Dubowsky J, Dubowsky E, Curtis J, Quarles D. Rapid loss of vertebral mineral density after renal transplantation. N Engl J Med 1991; 325: 544.
15. Hordon LD, Peacock M. Vitamin D metabolism in women with femoral neck fracture. Bone Miner 1987; 2: 413.
16. 2 D secretion after kidney transplant depends on the previous levels of 25 (OH) D. In: Norman AW, Bouillon R, Thomasset M, eds. Vitamin D. New York: Walter de Gruyter, 1994: 669.